Literature DB >> 30610197

Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.

Olav B Smeland1, Shahram Bahrami2, Oleksandr Frei2, Alexey Shadrin2, Kevin O'Connell2, Jeanne Savage3, Kyoko Watanabe3, Florian Krull2, Francesco Bettella2, Nils Eiel Steen2, Torill Ueland2,4, Danielle Posthuma3,5, Srdjan Djurovic6,7, Anders M Dale8,9,10,11, Ole A Andreassen12.   

Abstract

Schizophrenia (SCZ) and bipolar disorder (BD) are severe mental disorders associated with cognitive impairment, which is considered a major determinant of functional outcome. Despite this, the etiology of the cognitive impairment is poorly understood, and no satisfactory cognitive treatments exist. Increasing evidence indicates that genetic risk for SCZ may contribute to cognitive impairment, whereas the genetic relationship between BD and cognitive function remains unclear. Here, we combined large genome-wide association study data on SCZ (n = 82,315), BD (n = 51,710), and general intelligence (n = 269,867) to investigate overlap in common genetic variants using conditional false discovery rate (condFDR) analysis. We observed substantial genetic enrichment in both SCZ and BD conditional on associations with intelligence indicating polygenic overlap. Using condFDR analysis, we leveraged this enrichment to increase statistical power and identified 75 distinct genomic loci associated with both SCZ and intelligence, and 12 loci associated with both BD and intelligence at conjunctional FDR < 0.01. Among these loci, 20 are novel for SCZ, and four are novel for BD. Most SCZ risk alleles (61 of 75, 81%) were associated with poorer cognitive performance, whereas most BD risk alleles (9 of 12, 75%) were associated with better cognitive performance. A gene set analysis of the loci shared between SCZ and intelligence implicated biological processes related to neurodevelopment, synaptic integrity, and neurotransmission; the same analysis for BD was underpowered. Altogether, the study demonstrates that both SCZ and BD share genetic influences with intelligence, albeit in a different manner, providing new insights into their genetic architectures.

Entities:  

Mesh:

Year:  2019        PMID: 30610197      PMCID: PMC6609490          DOI: 10.1038/s41380-018-0332-x

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  62 in total

Review 1.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Authors:  Michael F Green
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

2.  Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders.

Authors:  Kristian Wahlbeck; Jeanette Westman; Merete Nordentoft; Mika Gissler; Thomas Munk Laursen
Journal:  Br J Psychiatry       Date:  2011-05-18       Impact factor: 9.319

3.  A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale.

Authors:  Matcheri S Keshavan; David W Morris; John A Sweeney; Godfrey Pearlson; Gunvant Thaker; Larry J Seidman; Shaun M Eack; Carol Tamminga
Journal:  Schizophr Res       Date:  2011-10-12       Impact factor: 4.939

Review 4.  Bipolar disorder.

Authors:  Iria Grande; Michael Berk; Boris Birmaher; Eduard Vieta
Journal:  Lancet       Date:  2015-09-18       Impact factor: 79.321

5.  Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group.

Authors:  Carmen Simonsen; Kjetil Sundet; Anja Vaskinn; Astrid B Birkenaes; John A Engh; Ann Faerden; Halldóra Jónsdóttir; Petter Andreas Ringen; Stein Opjordsmoen; Ingrid Melle; Svein Friis; Ole A Andreassen
Journal:  Schizophr Bull       Date:  2009-05-14       Impact factor: 9.306

6.  General and specific cognitive deficits in schizophrenia: Goliath defeats David?

Authors:  Dwight Dickinson; J Daniel Ragland; James M Gold; Ruben C Gur
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

Review 7.  How should DSM-V criteria for schizophrenia include cognitive impairment?

Authors:  Richard S E Keefe; Wayne S Fenton
Journal:  Schizophr Bull       Date:  2007-06-13       Impact factor: 9.306

8.  Schizophrenia is a cognitive illness: time for a change in focus.

Authors:  René S Kahn; Richard S E Keefe
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

9.  Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden.

Authors:  Merete Nordentoft; Kristian Wahlbeck; Jonas Hällgren; Jeanette Westman; Urban Osby; Hassan Alinaghizadeh; Mika Gissler; Thomas Munk Laursen
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 10.  Schizophrenia.

Authors:  Michael J Owen; Akira Sawa; Preben B Mortensen
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

View more
  40 in total

1.  Associations Between Two Single-Nucleotide Polymorphisms in NINJ2 Gene and Risk of Psychiatric Disorders.

Authors:  Arezou Sayad; Soudeh Ghafouri-Fard; Mir Davood Omrani; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2019-12-23       Impact factor: 3.444

Review 2.  Discovery of shared genomic loci using the conditional false discovery rate approach.

Authors:  Olav B Smeland; Oleksandr Frei; Alexey Shadrin; Kevin O'Connell; Chun-Chieh Fan; Shahram Bahrami; Dominic Holland; Srdjan Djurovic; Wesley K Thompson; Anders M Dale; Ole A Andreassen
Journal:  Hum Genet       Date:  2019-09-13       Impact factor: 4.132

3.  Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study.

Authors:  Shahram Bahrami; Nils Eiel Steen; Alexey Shadrin; Kevin O'Connell; Oleksandr Frei; Francesco Bettella; Katrine V Wirgenes; Florian Krull; Chun C Fan; Anders M Dale; Olav B Smeland; Srdjan Djurovic; Ole A Andreassen
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

4.  Identification of Genetic Loci Shared Between Attention-Deficit/Hyperactivity Disorder, Intelligence, and Educational Attainment.

Authors:  Kevin S O'Connell; Alexey Shadrin; Olav B Smeland; Shahram Bahrami; Oleksandr Frei; Francesco Bettella; Florian Krull; Chun C Fan; Ragna B Askeland; Gun Peggy S Knudsen; Anne Halmøy; Nils Eiel Steen; Torill Ueland; G Bragi Walters; Katrín Davíðsdóttir; Gyða S Haraldsdóttir; Ólafur Ó Guðmundsson; Hreinn Stefánsson; Ted Reichborn-Kjennerud; Jan Haavik; Anders M Dale; Kári Stefánsson; Srdjan Djurovic; Ole A Andreassen
Journal:  Biol Psychiatry       Date:  2019-11-29       Impact factor: 13.382

Review 5.  Using Chronobiological Phenotypes to Address Heterogeneity in Bipolar Disorder.

Authors:  Robert Gonzalez; Suzanne D Gonzalez; Michael J McCarthy
Journal:  Mol Neuropsychiatry       Date:  2020-02-20

6.  Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach.

Authors:  Paris Alexandros Lalousis; Stephen J Wood; Lianne Schmaal; Katharine Chisholm; Sian Lowri Griffiths; Renate L E P Reniers; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Joseph Kambeitz; Rebekka Lencer; Christos Pantelis; Stephan Ruhrmann; Raimo K R Salokangas; Frauke Schultze-Lutter; Carolina Bonivento; Dominic Dwyer; Adele Ferro; Theresa Haidl; Marlene Rosen; Andre Schmidt; Eva Meisenzahl; Nikolaos Koutsouleris; Rachel Upthegrove
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

7.  Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions.

Authors:  Claudia Pisanu; Donatella Congiu; Giovanni Severino; Raffaella Ardau; Caterina Chillotti; Maria Del Zompo; Bernhard T Baune; Alessio Squassina
Journal:  Neuropsychopharmacology       Date:  2021-05-25       Impact factor: 8.294

Review 8.  The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology.

Authors:  Olav B Smeland; Oleksandr Frei; Anders M Dale; Ole A Andreassen
Journal:  Nat Rev Neurol       Date:  2020-06-11       Impact factor: 42.937

9.  A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder.

Authors:  Md Altaf-Ul-Amin; Kazuhisa Hirose; João V Nani; Lucas C Porta; Ljubica Tasic; Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Mirian A F Hayashi; Shigehiko Kanaya
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

10.  Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci.

Authors:  Olav B Smeland; Alexey Shadrin; Shahram Bahrami; Iris Broce; Martin Tesli; Oleksandr Frei; Katrine V Wirgenes; Kevin S O'Connell; Florian Krull; Francesco Bettella; Nils Eiel Steen; Leo Sugrue; Yunpeng Wang; Per Svenningsson; Manu Sharma; Lasse Pihlstrøm; Mathias Toft; Michael O'Donovan; Srdjan Djurovic; Rahul Desikan; Anders M Dale; Ole A Andreassen
Journal:  Biol Psychiatry       Date:  2020-02-08       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.